Cita APA

He, Q., Jing, H., Liaw, L., Gower, L., Vary, C., Hua, S., & Yang, X. (2017). Corrigendum: Suppression of Spry1 inhibits triple-negative breast cancer malignancy by decreasing EGF/EGFR mediated mesenchymal phenotype. Sci Rep.

Citación estilo Chicago

He, Qing, Hongyu Jing, Lucy Liaw, Lindsey Gower, Calvin Vary, Shucheng Hua, y Xuehui Yang. "Corrigendum: Suppression of Spry1 Inhibits Triple-negative Breast Cancer Malignancy By Decreasing EGF/EGFR Mediated Mesenchymal Phenotype." Sci Rep 2017.

Cita MLA

He, Qing, et al. "Corrigendum: Suppression of Spry1 Inhibits Triple-negative Breast Cancer Malignancy By Decreasing EGF/EGFR Mediated Mesenchymal Phenotype." Sci Rep 2017.